Brian Ackerman
Chief Executive Officer at VitaNova Therapeutics
Brian Ackerman is Chief Executive Officer at VitaNova Therapeutics, a biotechnology company focused on precision immunotherapies for cancer. He previously served as CEO at Piccolo Biosystems, Inc. and has expertise in precision medicine, diagnostics, drug discovery, fundraising, strategic partnerships, and company formation.
-
VitaNova Therapeutics Chief Executive Officer 2026–present · current
-
Piccolo Biosystems, Inc. Chief Executive Officer 2024–2026 · past
-
Solere Digital Ventures CoFounder 2020–2024 · past
-
Startup Weekend Advisor 2014–2020 · past
Education
-
Stanford University Technology Entrepreneurship · 2014
-
University of Washington Bachelor of Arts - BA, International/Global Studies
Organizations
See all 4-
VitaNova Therapeutics Chief Executive Officer 2026–present · current
-
Piccolo Biosystems, Inc. Chief Executive Officer 2024–2026 · past
-
Solere Digital Ventures CoFounder 2020–2024 · past
Education
-
Stanford University Technology Entrepreneurship · 2014
-
University of Washington Bachelor of Arts - BA, International/Global Studies
